Today Sponge
This article was originally published in The Tan Sheet
Executive Summary
Allendale Pharmaceuticals retains additional manufacturing site for export-only production of contraceptive device. Firm continues to work toward use of Accupac manufacturing plant in Mainland, Penn., although GMP issues at that site have delayed FDA approval of the Sponge. Second, unidentified facility has "impeccable GMP record," says Allendale, which is trying to raise $300,000-$500,000 in private investment to offset depleted funds from approval delays
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning